[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Joe__Bassey Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1201055889073082368.png) Typical African [@Joe__Bassey](/creator/twitter/Joe__Bassey) on x 250.8K followers
Created: 2025-05-10 16:47:50 UTC

Meet Alex Kintu, an Ugandan scientist at Gilead Sciences, is leading groundbreaking research on lenacapavir—a twice-yearly injectable for HIV prevention that showed XXX% efficacy in the PURPOSE X trial.

This marks a major breakthrough for adolescent girls and young women in high-risk regions such as South Africa and Uganda. 🇺🇬

![](https://pbs.twimg.com/media/Gqmi4FgWgAAU0YM.jpg)

XXXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1921245808533360854/c:line.svg)

**Related Topics**
[uganda](/topic/uganda)
[south africa](/topic/south-africa)
[women](/topic/women)
[girls](/topic/girls)
[breakthrough](/topic/breakthrough)
[marks](/topic/marks)
[gilead sciences](/topic/gilead-sciences)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/Joe__Bassey/status/1921245808533360854)